[Unusually long survival times in patients with advanced Hodgkin's disease (author's transl)].
Of 18 patients with advanced Hodgkin's disease who obtained a complete remission with a modified De Vita treatment protocol 15 maintained their complete remission for an average of 76 months till the end of the observation time.
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D008017:Life Expectancy; D011239:Prednisolone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone
Aussergewöhnlich lange Uberlebenszeit bei Patienten mit fortgeschrittenen Stadien einer Lymphogranulomatose.